Local Institution - 0368

Shenzhen, Guangdong 518036

0 studies enrolling now · 1 studies all time

What they study most

Multiple Myeloma

Studies at this site

• A Study to Evaluate Efficacy and Safety of Alnuctamab Compared to Standard of Care Regimens in Participants With Relapsed or Refractory Multiple Myeloma (RRMM) — Withdrawn before enrolling